Connect Biopharmaceuticals completes venture financing

Autoimmune, inflammation and cancer company Connect Biopharmaceuticals Ltd. (Suzhou, China) raised $20 million in a series A round led by Qiming Venture Partners on Jan. 24. Northern Light Venture Cap...